July 19, 2024 07:00 AM EDTUpdated 02:09 PM
People
Peer Review

Nadir Mah­mood re­turns to Nkar­ta a year af­ter leav­ing; BeiGene picks long­time Mer­ck ex­ec for CFO post

Alex Hoffman

Copy Chief

Kathy Wong

Editor

Max Bayer

Pharma Reporter

For new Nkar­ta pres­i­dent Nadir Mah­mood, home is where the heart is.

The five-year vet­er­an of the NK cell ther­a­py biotech is re­turn­ing af­ter a …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

Califf, on his way out at FDA, pre­dicts agency tug-of-war be­tween Ra­maswamy and RFK Jr.

A service from the Financial Times